Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 29, 2022

SELL
$12.15 - $35.28 $323,190 - $938,448
-26,600 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$30.49 - $48.49 $60,980 - $96,980
2,000 Added 8.13%
26,600 $908,000
Q2 2021

Aug 03, 2021

BUY
$36.62 - $51.69 $25,634 - $36,183
700 Added 2.93%
24,600 $1.11 Million
Q1 2021

May 11, 2021

BUY
$41.56 - $59.88 $128,836 - $185,628
3,100 Added 14.9%
23,900 $1.15 Million
Q4 2020

Feb 11, 2021

SELL
$36.08 - $56.47 $43,296 - $67,764
-1,200 Reduced 5.45%
20,800 $1.12 Million
Q3 2020

Nov 06, 2020

BUY
$33.26 - $40.48 $99,780 - $121,439
3,000 Added 15.79%
22,000 $812,000
Q4 2019

Jan 27, 2020

BUY
$18.96 - $29.84 $13,272 - $20,888
700 Added 3.83%
19,000 $556,000
Q2 2019

Aug 02, 2019

BUY
$19.57 - $24.1 $15,656 - $19,280
800 Added 4.57%
18,300 $402,000
Q4 2018

Feb 08, 2019

BUY
$11.24 - $18.5 $196,700 - $323,750
17,500 New
17,500 $221,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.06B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Yorktown Management & Research CO Inc Portfolio

Follow Yorktown Management & Research CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yorktown Management & Research CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Yorktown Management & Research CO Inc with notifications on news.